First Trimester In Utero Exposure to Methylphenidate
- 7 January 2013
- journal article
- research article
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 112 (2) , 73-76
Abstract
Methylphenidate is a centrally acting sympathomimetic used for the treatment of attention deficit/hyperactivity disorder in children and adolescents and for narcolepsy in adults. Despite the growing use among adult women, no reliable data on the prevalence of use during pregnancy have been published, and safety during pregnancy has not been established. We systematically reviewed available data on birth outcome after human in utero exposure to methylphenidate. Systematic searches in PubMed/Embase were performed from origin to August 2012, and data from Michigan Medicaid recipients, The Collaborative Perinatal Project and the Swedish Birth Registry were evaluated. Excluding three case reports, a total of 180 children exposed to methylphenidate in utero during first trimester were identified, among whom, four children with major malformations were observed. Methylphenidate exposure during pregnancy does not appear to be associated with a substantially (i.e. more than twofold) increased risk of congenital malformations.Keywords
This publication has 9 references indexed in Scilit:
- The use of medication against attention deficit hyperactivity disorder in Denmark: a drug use study from a national perspectiveEuropean Journal of Clinical Pharmacology, 2012
- Pregnancy outcome after in-utero exposure to methylphenidate: A prospective comparative cohort studyReproductive Toxicology, 2011
- Practice Parameter for the Use of Stimulant Medications in the Treatment of Children, Adolescents, and AdultsJournal of the American Academy of Child & Adolescent Psychiatry, 2002
- Chemically Induced Birth Defects2000
- Intravenous Pentazocine and Methylphenidate Abuse During PregnaAmerican Journal of Diseases of Children, 1993
- Frequency of Human Congenital MalformationsClinics in Perinatology, 1986
- Hyperactive Children Have Grown UpArchives of General Psychiatry, 1985
- Limb Malformations Following Maternal Use of Haloperidol1975
- THALIDOMIDE AND MALFORMATIONS IN LIVERPOOLThe Lancet, 1962